Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:23 PM UTC
| NCT Number | NCT06916806 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE1 |
| Target Enrollment | 72 participants |
| Active Locations | 7 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 15, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT06916806 is currently recruiting participants. This phase1 study for systemic lupus erythematosus is actively seeking new participants at 7 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06916806 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06916806 was last updated 3 weeks ago (September 15, 2026). HelloStudys verifies this status automatically.